MR. MICHAEL JOSEPH KELLY JR. PA-C
Prescription History 1740366111
Physician Assistant in Tulsa, OK


Quality Rating: 79.39 out of 100 score

NPI Status: Active since October 28, 2006

Contact Information

6585 S YALE AVE STE 720
TULSA, OK
ZIP 74136
Phone: (918) 502-5930
Fax: (918) 502-5935

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for MR. MICHAEL JOSEPH KELLY JR. PA-C, an active Physician Assistant specialist practicing in Tulsa, OK. Our medical registry currently tracks 10 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 505 documented patient claims. Among these therapy options, the most frequently utilized medication is Tamsulosin Hcl, which accounts for 208 claims alone.


Alfuzosin Hcl Er

Generic Formulation: Alfuzosin HclSpecialty: Physician Assistant
Provider Metrics Summary
Total Claims 13
30-Day Fills 31.0
Days Supply 930
OK State Average Benchmarks
Peer Average Claims37.0
Peer Average 30-Day Fills84.9
Peer Average Days Supply2,539
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 64.9% less volume than the regional standard for practitioners inside OK. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $263.70 across this reporting matrix range.

Provider Avg Cost Per Claim

$20.28

State Avg Cost Per Claim

$27.23

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Alfuzosin is used by men to treat the symptoms of an enlarged prostate (benign prostatic hyperplasia-BPH). It does not shrink the prostate, but it works by relaxing the muscles in the prostate and the bladder. This helps to relieve symptoms of BPH such as difficulty in beginning the flow of urine, weak stream, and the need to urinate often or urgently (including during the middle of the night). Alfuzosin belongs to a class of drugs known as alpha blockers. Do not use this medication to treat high blood pressure.

Cephalexin

Generic Formulation: CephalexinSpecialty: Physician Assistant
Provider Metrics Summary
Total Claims 37
30-Day Fills 57.7
Days Supply 1,240
OK State Average Benchmarks
Peer Average Claims30.0
Peer Average 30-Day Fills32.5
Peer Average Days Supply350
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across OK. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $241.06 across this reporting matrix range.

Provider Avg Cost Per Claim

$6.52

State Avg Cost Per Claim

$8.80

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A semisynthetic cephalosporin antibiotic with antimicrobial activity similar to that of CEPHALORIDINE or CEPHALOTHIN, but somewhat less potent. It is effective against both gram-positive and gram-negative organisms.

Therapeutic Applications

This medication is used to treat a wide variety of bacterial infections. This medication is known as a cephalosporin antibiotic. It works by stopping the growth of bacteria. This medication will not work for viral infections (such as common cold, flu). Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness.

Ciprofloxacin Hcl

Generic Formulation: Ciprofloxacin HclSpecialty: Physician Assistant
Provider Metrics Summary
Total Claims 16
30-Day Fills 16.0
Days Supply 189
OK State Average Benchmarks
Peer Average Claims28.0
Peer Average 30-Day Fills28.7
Peer Average Days Supply258
Conservative Utilization

This provider writes prescriptions for this formulation 42.9% less frequently than the standard regional baseline metric for practitioners inside OK. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $169.96 across this reporting matrix range.

Provider Avg Cost Per Claim

$10.62

State Avg Cost Per Claim

$8.62

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A broad-spectrum antimicrobial carboxyfluoroquinoline.

Therapeutic Applications

This medication is used to treat eye infections. Ciprofloxacin belongs to a class of drugs called quinolone antibiotics. It works by stopping the growth of bacteria. This medication treats only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness.

Finasteride

Generic Formulation: FinasterideSpecialty: Physician Assistant
Provider Metrics Summary
Total Claims 60
30-Day Fills 174.0
Days Supply 5,200
OK State Average Benchmarks
Peer Average Claims53.0
Peer Average 30-Day Fills123.0
Peer Average Days Supply3,661
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across OK. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,431.28 across this reporting matrix range.

Provider Avg Cost Per Claim

$23.85

State Avg Cost Per Claim

$16.88

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An orally active 3-OXO-5-ALPHA-STEROID 4-DEHYDROGENASE inhibitor. It is used as a surgical alternative for treatment of benign PROSTATIC HYPERPLASIA.

Therapeutic Applications

Finasteride is used to shrink an enlarged prostate (benign prostatic hyperplasia or BPH) in adult men. It may be used alone or taken in combination with other medications to reduce symptoms of BPH and may also reduce the need for surgery. Finasteride may improve symptoms of BPH and provide benefits such as decreased urge to urinate, better urine flow with less straining, less of a feeling that the bladder is not completely emptied, and decreased nighttime urination. This medication works by decreasing the amount of a natural body hormone (DHT) that causes growth of the prostate. Finasteride is not approved for prevention of prostate cancer. It may slightly increase the risk of developing a very serious form of prostate cancer. Talk to your doctor about the benefits and risks. Women and children should not use this medication.

Gemtesa

Generic Formulation: VibegronSpecialty: Physician Assistant
Provider Metrics Summary
Total Claims 53
30-Day Fills 78.0
Days Supply 2,340
OK State Average Benchmarks
Peer Average Claims43.0
Peer Average 30-Day Fills53.5
Peer Average Days Supply1,404
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across OK. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $35,919.85 across this reporting matrix range.

Provider Avg Cost Per Claim

$677.73

State Avg Cost Per Claim

$519.78

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat overactive bladder. Overactive bladder is a problem with how your bladder stores urine that causes a sudden urge to urinate. The urge may be hard to control, and overactive bladder symptoms may include frequent urination, strong sudden urges to urinate, or involuntary loss of urine (incontinence). Vibegron works by relaxing a certain bladder muscle (detrusor), which helps the bladder hold more urine and lessens symptoms of overactive bladder.

Myrbetriq

Generic Formulation: MirabegronSpecialty: Physician Assistant
Provider Metrics Summary
Total Claims 56
30-Day Fills 106.3
Days Supply 3,190
OK State Average Benchmarks
Peer Average Claims42.0
Peer Average 30-Day Fills62.3
Peer Average Days Supply1,739
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 33.3% more claims than the standard regional baseline profile for OK. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $48,063.72 across this reporting matrix range.

Provider Avg Cost Per Claim

$858.28

State Avg Cost Per Claim

$617.42

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat certain bladder problems (overactive bladder, neurogenic detrusor overactivity). Overactive bladder is a problem with how your bladder stores urine. Neurogenic detrusor overactivity is a bladder control condition caused by brain, spinal cord, or nerve problems. Symptoms of these conditions may include frequent urination, strong sudden urges to urinate that are hard to control, or involuntary loss of urine (incontinence). Mirabegron works by relaxing a certain bladder muscle (detrusor), which helps the bladder hold more urine and lessens symptoms of overactive bladder and neurogenic detrusor overactivity.

Oxybutynin Chloride

Generic Formulation: Oxybutynin ChlorideSpecialty: Physician Assistant
Provider Metrics Summary
Total Claims 12
30-Day Fills 14.1
Days Supply 336
OK State Average Benchmarks
Peer Average Claims31.0
Peer Average 30-Day Fills49.1
Peer Average Days Supply1,414
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 61.3% less volume than the regional standard for practitioners inside OK. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $216.24 across this reporting matrix range.

Provider Avg Cost Per Claim

$18.02

State Avg Cost Per Claim

$23.74

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This is a long-acting form of oxybutynin that is used to treat overactive bladder and urinary conditions. It relaxes the muscles in the bladder to help decrease problems of urgency and frequent urination. Oxybutynin belongs to a class of drugs known as antispasmodics. This medication is also used to treat children 6 years of age and older who have an overactive bladder due to certain nerve disorders (such as spina bifida).

Oxybutynin Chloride Er

Generic Formulation: Oxybutynin ChlorideSpecialty: Physician Assistant
Provider Metrics Summary
Total Claims 25
30-Day Fills 50.0
Days Supply 1,486
OK State Average Benchmarks
Peer Average Claims31.0
Peer Average 30-Day Fills57.5
Peer Average Days Supply1,685
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across OK. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $926.03 across this reporting matrix range.

Provider Avg Cost Per Claim

$37.04

State Avg Cost Per Claim

$41.91

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This is a long-acting form of oxybutynin that is used to treat overactive bladder and urinary conditions. It relaxes the muscles in the bladder to help decrease problems of urgency and frequent urination. Oxybutynin belongs to a class of drugs known as antispasmodics. This medication is also used to treat children 6 years of age and older who have an overactive bladder due to certain nerve disorders (such as spina bifida).

Sulfamethoxazole-Trimethoprim

Generic Formulation: Sulfamethoxazole/TrimethoprimSpecialty: Physician Assistant
Provider Metrics Summary
Total Claims 25
30-Day Fills 25.0
Days Supply 294
OK State Average Benchmarks
Peer Average Claims27.0
Peer Average 30-Day Fills30.4
Peer Average Days Supply418
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across OK. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $310.45 across this reporting matrix range.

Provider Avg Cost Per Claim

$12.42

State Avg Cost Per Claim

$6.82

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A drug combination with broad-spectrum antibacterial activity against both gram-positive and gram-negative organisms. It is effective in the treatment of many infections, including PNEUMOCYSTIS PNEUMONIA in AIDS.

Therapeutic Applications

This medication is a combination of two antibiotics: sulfamethoxazole and trimethoprim. It is used to treat a wide variety of bacterial infections (such as middle ear, urine, respiratory, and intestinal infections). It is also used to prevent and treat a certain type of pneumonia (pneumocystis-type). This medication should not be used by children less than 2 months of age due to the risk of serious side effects. This medication treats only certain types of infections. It will not work for viral infections (such as flu). Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness.

Tamsulosin Hcl

Generic Formulation: Tamsulosin HclSpecialty: Physician Assistant
Provider Metrics Summary
Total Claims 208
30-Day Fills 556.3
Days Supply 16,690
OK State Average Benchmarks
Peer Average Claims82.0
Peer Average 30-Day Fills177.1
Peer Average Days Supply5,241
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 153.7% higher than the standard regional baseline profile for OK. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $6,482.09 across this reporting matrix range.

Provider Avg Cost Per Claim

$31.16

State Avg Cost Per Claim

$19.60

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Tamsulosin is used by men to treat the symptoms of an enlarged prostate (benign prostatic hyperplasia-BPH). It does not shrink the prostate, but it works by relaxing the muscles in the prostate and the bladder. This helps to relieve symptoms of BPH such as difficulty in beginning the flow of urine, weak stream, and the need to urinate often or urgently (including during the middle of the night). Tamsulosin belongs to a class of drugs known as alpha blockers. Do not use this medication to treat high blood pressure.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like MR. MICHAEL JOSEPH KELLY JR. PA-C provides transparency into local medical care patterns within Tulsa, OK.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Physician Assistant** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.